Mark Perrin

2015

In 2015, Mark Perrin earned a total compensation of $1.9M as Chief Executive Officer and Chairman of the Board at InVivo Therapeutics Holdings, a 64% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$215,000
Option Awards$1,083,088
Salary$421,395
Other$200,618
Total$1,920,101

Perrin received $1.1M in option awards, accounting for 56% of the total pay in 2015.

Perrin also received $215K in non-equity incentive plan, $421.4K in salary and $200.6K in other compensation.

Rankings

In 2015, Mark Perrin's compensation ranked 4,882nd out of 13,638 executives tracked by ExecPay. In other words, Perrin earned more than 64.2% of executives.

ClassificationRankingPercentile
All
4,882
out of 13,638
64th
Division
Manufacturing
1,800
out of 5,190
65th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
236
out of 760
69th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
133
out of 466
72nd
Industry
Surgical and Medical Instruments and Apparatus
71
out of 293
76th
Source: SEC filing on April 25, 2017.

Perrin's colleagues

We found five more compensation records of executives who worked with Mark Perrin at InVivo Therapeutics Holdings in 2015.

2015

Lorianne Masuoka

InVivo Therapeutics Holdings

Chief Medical Officer

2015

Thomas Ulich

InVivo Therapeutics Holdings

Chief Scientific Officer

2015

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

2015

Christopher McNulty

InVivo Therapeutics Holdings

Chief Financial Officer

2015

Steven McAllister

InVivo Therapeutics Holdings

Chief Financial Officer

In-depth

You may also like